Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Inherit Metab Dis ; 21(4): 373-81, 1998 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-9700594

RESUMO

It has been reported that children with classical phenylketonuria (PKU) have reduced levels of arachidonic acid (AA, 20:4 n-6) and docosahexaenoic acid (DHA, 22:6 n-3) in plasma and membrane phospholipids compared to controls and may therefore require supplementation. However, it is not established that these changes are specific for PKU. They may as well be attributed to the specific composition of a largely vegetarian diet used for dietary PKU treatment. We therefore investigated the fatty acid composition of plasma phospholipids (PL), plasma cholesterol esters (CE), red blood cell phosphatidylcholine (PC), and red blood cell phosphatidylethanolamine (PE) in two groups of PKU patients including 8 children between 1 and 6 years (group A), 9 adolescents between 11 and 18 years (group B), and 20 age-matched healthy controls. Group A had good dietary control (median plasma phenylalanine 272 mumol/L during the last 6 months before phospholipid analysis) while median phenylalanine in group B was 714 mumol/L (p < 0.001). When compared to age-matched controls, group A showed significantly lower DHA levels in PE (4.21 vs 5.85 weight% (wt%), p < 0.01), in PC (1.02 vs 1.25 wt%, p < 0.05) and in CE (0.25 vs 0.54 wt%, p < 0.05). There was no significant difference of DHA between group B and controls. AA levels were similar in phospholipids of all groups. We conclude that reduced levels of long-chain polyunsaturated fatty acids in PKU patients occur only in those patients with strict dietary therapy with respect to n-3 fatty acids, most probably caused by reduced intake of n-3 fatty acids.


Assuntos
Membrana Eritrocítica/metabolismo , Ácidos Graxos Insaturados/sangue , Ácido Linoleico/administração & dosagem , Fenilcetonúrias/sangue , Adolescente , Criança , Pré-Escolar , Ingestão de Alimentos , Eritrócitos/metabolismo , Humanos , Lactente , Lipídeos de Membrana/sangue , Fosfolipídeos/sangue
2.
Acta Paediatr ; 86(10): 1144-7, 1997 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-9350903

RESUMO

We describe a male patient with glutaric aciduria type I which had already presented during the neonatal period with therapy-resistant seizures. In the course of the disease, he also developed choreoathetosis and dystonia. The disease was associated with nephrotic syndrome. Renal histology showed signs of a glomerular disorder with shrinking of glomerular tufts, increase in mesangial matrix, proliferation of extracapillary epithelial cells and formation of larger epithelial crescents. The child died at 22 weeks of age due to end-stage renal failure. This report illustrates an unusual and early clinical manifestation of glutaric aciduria type I and a hitherto unknown association with nephrotic syndrome in early childhood.


Assuntos
Erros Inatos do Metabolismo/complicações , Síndrome Nefrótica/complicações , Oxirredutases atuantes sobre Doadores de Grupo CH-CH , Oxirredutases/deficiência , Evolução Fatal , Glutaril-CoA Desidrogenase , Humanos , Recém-Nascido , Rim/patologia , Masculino , Erros Inatos do Metabolismo/patologia , Síndrome Nefrótica/diagnóstico , Síndrome Nefrótica/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...